Is early steroid withdrawal after liver transplantation feasible with tacrolimus monotherapy?
Everson
Gregory T
GT
University of Colorado Health Sciences Center, UCH AOP Room 7085, 1635 N Ursula B-154, PO Box 6510, Aurora, CO 80045, USA. greg.everson@uchsc.edu
D004311:Double-Blind Method; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000009:adverse effects; D006084:Graft Rejection / Q000188:drug therapy; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016031:Liver Transplantation; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000009:adverse effects; D016559:Tacrolimus / Q000008:administration & dosage*; D016896:Treatment Outcome
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D016559:Tacrolimus; D008775:Methylprednisolone